Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Repositioning of 3-(isoxazol-3-yl)thiazolidin-4-one-based compounds via Inverse Virtual Screening: discovery of new ERα inhibitors with in vitro activity in breast cancer models.

European journal of medicinal chemistry·2026

Same author

Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity.

International journal of molecular sciences·2026

Same author

F2F-202, a Selective Histone Deacetylase 6 (HDAC6) Inhibitor, Behaves as an Arrow with Multiple Tips against Azole-Resistant <i>C. albicans</i>: Modulation of Yeast-to-Hyphae Transition, Trailing Effect, and Oxidative Stress.

ACS infectious diseases·2026

Same author

Upcycling lemon peel waste into sustainable bioactive ingredients: chemical characterization and efficacy assessment.

The Analyst·2026

Same author

Modulating STAT3 pathway in breast cancer: Improved activity of T40214 aptamer by peptide-based nanofibers delivering.

International journal of biological macromolecules·2026

Same author

Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity.

International journal of biological macromolecules·2026

Search research articles

Related Experiment Video

Updated: May 7, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

A new design for nucleolipid-based Ru(III) complexes as anticancer agents.

Daniela Montesarchio¹, Gaetano Mangiapia, Giuseppe Vitiello

¹Department of Chemical Sciences, University of Napoli "Federico II", Complesso Universitario di Monte Sant'Angelo, via Cintia 21, I-80126, Napoli, Italy. daniela.montesarchio@unina.it.

Dalton Transactions (Cambridge, England : 2003)

|October 15, 2013

Summary

A novel uridine-based Ruthenium(III) complex, HoUrRu, was synthesized and formulated with lipids. This nucleolipid formulation demonstrated significant antiproliferative activity against human cancer cell lines.

More Related Videos

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

Related Experiment Videos

Last Updated: May 7, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

Area of Science:

Medicinal Chemistry
Materials Science
Biotechnology

Background:

Nucleolipidic Ruthenium(III) complexes are explored for anticancer properties.
Development of novel Ru(III) complexes requires versatile synthetic strategies.
Formulation of metal complexes can enhance stability and delivery.

Purpose of the Study:

To synthesize and characterize a novel uridine-based nucleolipid Ru(III) complex, HoUrRu.
To formulate HoUrRu with zwitterionic (POPC) and cationic (DOTAP) lipids.
To evaluate the in vitro antiproliferative activity of HoUrRu and its formulations.

Main Methods:

Synthesis of uridine-based nucleolipid.
Formation of Ru(III) salt.
Co-aggregation with POPC and DOTAP lipids.
Microstructural characterization using DLS, SANS, and EPR.
In vitro antiproliferative assays against MCF-7 and WiDr cell lines.

Main Results:

A novel uridine-based nucleolipid Ru(III) complex, HoUrRu, was successfully synthesized.
Stable formulations of HoUrRu were achieved through co-aggregation with POPC and DOTAP.
HoUrRu, both pure and formulated, exhibited high antiproliferative activity against human cancer cell lines (MCF-7, WiDr).

Conclusions:

HoUrRu represents a promising new nucleolipidic Ru(III) complex for cancer therapy.
Lipid formulation enhances the delivery and potential efficacy of HoUrRu.
Further investigation into HoUrRu's mechanism of action and in vivo studies are warranted.